Intrinsic Value of S&P & Nasdaq Contact Us

Forian Inc. FORA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
$95.65
+4328.2%
Analyst Price Target
$4.50
+108.3%

Forian Inc. (FORA) generated $3.22M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $0.00, free cash flow was $3.22M.

Free cash flow margin was 40.5% of revenue. Cash conversion ratio was -1.77x, suggesting some earnings are non-cash.

The company returned $172.3K in share buybacks to shareholders during the quarter.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (35/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (10/100) — Cash conversion ratio was -1.77x suggests some earnings are non-cash items

Overall SharesGrow Score: 57/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
57/100
SG Score
View full scorecard →
VALUE
91/100
Price-to-Earnings & upside
→ Valuation
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
35/100
Proven by this page
GROWTH
73/100
→ Income
INCOME
10/100
→ Income
Forian Inc. Cash Flow History
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Operating Cash Flow $2.89M$3.22M$-439.67K$-344.53K$448.18K
Capital Expenditure $0.00$0.00$0.00$0.00$0.00
Free Cash Flow $2.89M$3.22M$-439.67K$-344.53K$448.18K
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message